Cairo, Egypt and Villejuif & Buc, France – September 7, 2021
Speeding up Breast Cancer Diagnosis in Egypt: GE Healthcare, Gustave Roussy and the Egypt Ministry of Health Partner to Create Rapid Breast Cancer Diagnosis Clinics
GE Healthcare, Gustave Roussy and the Egypt Ministry of Health (MOH) signed a preliminary agreement leveraging Gustave Roussy’s One Stop Breast Cancer diagnostics program to increase the speed and the accuracy of breast cancer diagnosis in Egypt.
Le gliome infiltrant du tronc cérébral (GITC ou DIPG en anglais pour Diffuse Intrinsec Pontine Glioma) est une tumeur cérébrale maligne très agressive localisée dans une partie du tronc cérébral appelée le pont.
Cancer affects 35,000 young people every year in Europe, including approximately 2,500 in France. As the primary cause of death by disease in children and adolescents, it is responsible for 6,000 deaths annually across Europe, including 500 in France.
To understand the mechanisms of resistance to innovative therapies, Gustave Roussy has launched the Unlock medical-scientific programme as part of its Institutional Strategic Project 2020-2030.This programme aims to understand these mechanisms and identify new targets in order to develop medical strategies to prevent or bypass them.